Clinical Trial Update: Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating daily tenofovir disoproxil fumarate to prevent HIV infection among sex workers in Cambodia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir Disoproxil Fumarate (Viread) (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Seronegativity | Phase 2, Phase 3 | Status: WITHDRAWN